Pharmacokinetic and pharmacodynamics of intravenous dexmedetomidine in morbidly obese patients undergoing laparoscopic surgery
ConclusionThe pharmacokinetics and pharmacodynamics of dexmedetomidine are significantly different in morbidly obese patients compared with normal weight patients. Level of sedation was significantly deeper, and oxygen saturation was significantly lower, in morbidly obese than in normal weight patients, probably resulting from higher plasma concentration after infusion of 1.0 µg/kg.Clinical trial number, registry URLClinicalTrials.gov (NCT01864187),https://register.clinicaltrials.gov/prs/app/action/LoginUser?ts=1&cx=-jg9qo4.
Source: Journal of Anesthesia - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Clinical Trials | Diprivan | Eating Disorders & Weight Management | Fentanyl | Heart | Laparoscopy | Obesity | Propofol | Study